He is an antibiotics researcher who not only promises new antibiotics, but also to make existing antibiotics more efficient. The potential should be peer reviewed. Not particularly novel in its methods, all the big ones use ‘AI’ to find new molecules. Standard problems of antimicrobiotical research apply to his team as well: no-one funds it, because it’s not lucrative. | Relevance/ Impact: High, actual problem, global impact | Structure/Performance: Well structured. If we look for a Russian Arnold Schwarzenegger to lighten the mood, this is our man.

Tags: Bio-Tech, Med-Tech